Particulars |
|
|
|
Company Name
| Glaxosmithkline Pharmaceuticals Ltd
| Year End
| 202303
|
Full Year |
Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
91.40 |
Sales(₹ Cr.) |
3,216.34 |
NP (₹ Cr.) |
586.70 |
NP Var (%) |
-65.00 |
Div% |
320.00 |
CPS(₹) |
38.50 |
EPS (₹) |
34.60 |
Traded Value(₹ Lakhs) |
183.53 |
52 Week High |
2,650.00 |
52 Week Low |
1,242.00 |
Price BSE |
2,094.00 |
Price NSE |
2,095.00 |
Market Capital (₹ Cr.) |
35,471.08 |
P/C Ratio |
54.40 |
P/E Ratio |
60.50 |
Price Vs.BV |
22.91 |
|
Latest Quarter |
Year End |
202312 |
Sales (₹ Cr.) |
804.98 |
NP(₹ Cr.) |
177.48 |
NP Var % |
3.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
3,234.97 |
OPM |
27.59 |
NP |
412.71 |
NP Var (%) |
46.73 |
EPS |
37.52 |
PE |
55.81 |
|
|